{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:44:33Z","timestamp":1773265473502,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jconrel.2021.05.019","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:12:53Z","timestamp":1621383173000},"page":"203-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"335","author":[{"given":"Sriram","family":"Kannan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifat","family":"Harel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esthy","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishay","family":"Dolitzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf E.","family":"Sagiv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurav","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulamit","family":"Michaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.05.019_bb0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2005.08.016","article-title":"Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani","volume":"145","author":"Mukherjee","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-003-0201-2","article-title":"Miltefosine (Impavido): the first oral treatment against leishmaniasis","volume":"193","author":"Sindermann","year":"2004","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.17.5.787","article-title":"Paromomycin in the treatment of leishmaniasis","volume":"17","author":"Sundar","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006310","article-title":"Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria","volume":"12","author":"Eddaikra","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9014726","article-title":"Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review","volume":"2018","author":"Berbert","year":"2018","journal-title":"Dermatol. Res. Pract."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/02652049809006875","article-title":"Study of azathioprine encapsulation into liposomes","volume":"15","author":"Gulati","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0060","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2217\/nnm.12.74","article-title":"Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies","volume":"7","author":"Costa Lima","year":"2012","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm85040036","article-title":"Leishmanicidal activity of biogenic Fe3O4 nanoparticles","volume":"85","author":"Khatami","year":"2017","journal-title":"Sci. Pharm"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0070","first-page":"6","article-title":"In vitro study on cytotoxic effects of ZnO nanoparticles on promastigote and amastigote forms of Leishmania major (MRHO\/IR\/75\/ER)","volume":"9","author":"Delavari","year":"2014","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.actatropica.2017.10.027","article-title":"Biogenic silver nanoparticles inducing Leishmania amazonensis promastigote and amastigote death in vitro","volume":"178","author":"Fanti","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0080","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1021\/acsanm.8b00213","article-title":"Antiparasitic ointment based on a Biocompatibile carbon dot Nanocomposite","volume":"1","author":"Kumar","year":"2018","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0085","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/acs.bioconjchem.5b00276","article-title":"MagRET nanoparticles: an Iron oxide Nanocomposite platform for gene silencing from MicroRNAs to long noncoding RNAs","volume":"26","author":"Lellouche","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0090","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1039\/C4TB00634H","article-title":"Ce3\/4+ cation-functionalized maghemite nanoparticles towards siRNA-mediated gene silencing","volume":"2","author":"Israel","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0095","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M008405200","article-title":"Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000739","article-title":"Social motility in African trypanosomes","volume":"6","author":"Oberholzer","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004493","article-title":"Social motility of African trypanosomes is a property of a distinct life-cycle stage that occurs early in tsetse Fly transmission","volume":"10","author":"Imhof","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0110","series-title":"Exosome Secretion Affects Social Motility in Trypanosoma brucei","author":"Eliaz","year":"2017"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/s19224957","article-title":"Automatic focus assessment on dermoscopic images acquired with smartphones","volume":"19","author":"Alves","year":"2019","journal-title":"Sensors (Switzerland)"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0120","article-title":"Melanoma is skin deep: a 3d reconstruction technique for computerized dermoscopic skin lesion classification","volume":"5","author":"Satheesha","year":"2017","journal-title":"IEEE J. Transl. Eng. Heal. Med"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0125","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/IAI.71.12.6689-6692.2003","article-title":"Review of the use of statistics in infection and immunity","volume":"71","author":"Olsen","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0130","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1021\/acsami.5b02743","article-title":"Acute in vivo toxicity mitigation of PEI-coated Maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery","volume":"7","author":"Israel","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0135","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mib.2012.03.002","article-title":"Form and function in the trypanosomal secretory pathway","volume":"15","author":"Silverman","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","article-title":"The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus","volume":"430","author":"Lund","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020193906974","article-title":"Tetramethyl rhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin","volume":"19","author":"Floryk","year":"1999","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.pt.2015.06.012","article-title":"The social life of African trypanosomes","volume":"31","author":"Imhof","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/00034983.1986.11812057","article-title":"In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate","volume":"80","author":"El-On","year":"1986","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13344-6","article-title":"Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania","volume":"10","author":"Bhattacharya","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ab.2005.06.011","article-title":"Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies","volume":"344","author":"Didenko","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006980","article-title":"Insights into antitrypanosomal drug mode-of-action from cytology-based profiling","volume":"12","author":"Thomas","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9078","article-title":"Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1","volume":"6","author":"Vanwalleghem","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0185","first-page":"23","article-title":"Cytotoxic impacts of linear and branched Polyethylenimine nanostructures in A431 cells","volume":"1","author":"Omidi","year":"2011","journal-title":"BioImpacts."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0190","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","article-title":"Nanostructured delivery systems with improved leishmanicidal activity: a critical review","volume":"12","author":"Bruni","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Balasegaram 2012","author":"Balasegaram","year":"2012","journal-title":"Expert Opin. Emerg. Drugs."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0200","first-page":"2663","article-title":"Overexpressed macrophage mannose receptor targeted nanocapsules- mediated cargo delivery approach for eradication of resident parasite: in vitro and in vivo studies","volume":"32","author":"Asthana","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0205","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11095-014-1571-4","article-title":"Self assembled Ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral Leishmaniasis","volume":"32","author":"Gupta","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0210","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","article-title":"Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses","volume":"156","author":"Zerpa","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0215","article-title":"Overcoming the challenge; in vivo efficacy of miltefosine for chronic cutaneous leishmaniasis","volume":"29","author":"Tunal","year":"2020","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0220","first-page":"288","article-title":"Topical treatment of cutaneous Leishmaniasis in Israel, part 2","volume":"23","author":"Zur","year":"2019","journal-title":"Int J Pharm Compd."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0225","article-title":"Topical paromomycin for New World cutaneous leishmaniasis","volume":"13","author":"Id","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL\/6 model","volume":"1","author":"Lecoeur","year":"2007","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006653","article-title":"A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia","volume":"12","author":"L\u00f3pez","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpddr.2019.02.002","article-title":"Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis","volume":"11","author":"Van Bocxlaer","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis\u202f: the melarsoprol and pentamidine story chemotherapy against African trypanosomiasis Europe PMC funders author manuscripts the diamidines","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2021.05.019_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24203744","article-title":"Biodegradable polymers for gene delivery","volume":"24","author":"Thomas","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.05.019_bb0255","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1073\/pnas.87.24.9736","article-title":"Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes","volume":"87","author":"LeBowitz","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921002352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921002352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:59:31Z","timestamp":1759161571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":51,"alternative-id":["S0168365921002352"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}